Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/25461
Appears in Collections:Aquaculture Journal Articles
Peer Review Status: Refereed
Title: Hepatic Proteome Analysis of Atlantic Salmon (Salmo salar) After Exposure to Environmental Concentrations of Human Pharmaceuticals
Authors: Hampel, Miriam
Alonso, Esteban
Aparicio, Irene
Santos, Juan Luis
Leaver, Michael
Contact Email: mjl1@stir.ac.uk
Issue Date: 1-Feb-2015
Citation: Hampel M, Alonso E, Aparicio I, Santos JL & Leaver M (2015) Hepatic Proteome Analysis of Atlantic Salmon (Salmo salar) After Exposure to Environmental Concentrations of Human Pharmaceuticals, Molecular and Cellular Proteomics, 14 (2), pp. 371-381.
Abstract: Pharmaceuticals are pseudopersistent aquatic pollutants with unknown effects at environmentally relevant concentrations. Atlantic salmon (Salmo salar) were exposed to Acetaminophen: 54.77 ± 34.67; Atenolol: 11.08 ± 7.98, and Carbamazepine: 7.85 ± 0.13 μg·L−1for 5 days. After Acetaminophen treatment, 19 proteins were differently expressed, of which 11 were significant with respect to the control group (eight up-regulated and three down-regulated). After Atenolol treatment, seven differently expressed proteins were obtained in comparison with the control, of which six could be identified (four up-regulated and two down-regulated). Carbamazepine exposure resulted in 15 differently expressed proteins compared with the control, with 10 of them identified (seven up-regulated and three down-regulated). Out of these, three features were common between Acetaminophen and Carbamazepine and one between Carbamazepine and Atenolol. One feature was common across all treatments. Principal component analysis and heat map clustering showed a clear grouping of the variability caused by the applied treatments. The obtained data suggest (1) that exposure to environmentally relevant concentrations of the pharmaceuticals alters the hepatic protein expression profile of the Atlantic salmon; and (2) the existence of treatment specific processes that may be useful for biomarker development.
DOI Link: http://dx.doi.org/10.1074/mcp.M114.045120
Rights: Publisher policy allows this work to be made available in this repository. Published in Molecular & Cellular Proteomics, 14, 371-381 by American Society for Biochemistry and Molecular Biology. The original publication is available at: https://doi.org/10.1074/mcp.M114.045120

Files in This Item:
File Description SizeFormat 
Mol Cell Proteomics-2015-Hampel-371-81.pdf947.56 kBAdobe PDFView/Open



This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.